ArticleACS medicinal chemistry letters2025

Farnesyl Transferase Inhibitors as a Novel Strategy for Targeting KRAS-Dependent Cancers.

Robert B KargboPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.